| Literature DB >> 30234023 |
Yiman Li1, Licui Sun2, Chunyan Lu3, Ying Gong1, Min Li3, Shujuan Sun3.
Abstract
In recent decades, invasive fungal infections have been increasing significantly, contributing to high incidences and mortality in immunosuppressed patients. Candida albicans (C. albicans) is the most prevalent opportunistic fungal pathogen in humans that can cause severe and often fatal bloodstream infections. Current antifungal agents have several limitations, including that only a small number of classes of antifungals are available, certain of which have severe toxicity and high cost. Moreover, the emergence of drug resistance is a new limitation to successful patient outcomes. Therefore, the development of antifungals with novel targets is an essential strategy for the efficient management of C. albicans infections. It is widely recognized that ion homeostasis is crucial for all living cells. Many studies have identified that ion-signaling and transduction networks are central to fungal survival by regulating gene expression, morphological transition, host invasion, stress response, and drug resistance. Dysregulation of ion homeostasis rapidly mediates cell death, forming the mechanistic basis of a growing number of compounds that elicit antifungal activity. Most of the potent antifungals have been widely used in the clinic, and certain of them have low toxicity, meaning that they may be expected to be used as antifungal drugs in the future. Hence, we briefly summarize the homeostasis regulation of several important ions, potential antifungal targets based on these ion-signaling networks, and antifungal compounds based on the disruption of ion homeostasis. This summary will help in designing effective drugs and identifying new targets for combating fungal diseases.Entities:
Keywords: Candida albicans; antifungal targets; ion homeostasis; ion signaling pathways; virulence
Mesh:
Substances:
Year: 2018 PMID: 30234023 PMCID: PMC6131588 DOI: 10.3389/fcimb.2018.00286
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Schematic diagram depicting the regulation of different ion systems, their role in fungal growth, as well as the potential antifungal targets based on ion signaling pathways in C. albicans. Different ions correspond to different colors, H+(green); Ca2+(mazarine); Fe3+(purple); Zn2+(gray); K+(blue); and Na+ (pink). CaM, calmodulin; CnA, the a subunit of calcineurin; CnB, the b subunit of calcineurin. Further details are provided in the text.
Figure 2Overview of the relationship between the specific protein and fungal survival, tolerance, and virulence in different ion regulating systems. (A–C) represent H+, Ca2+, and Fe3+ homeostasis, respectively. (D) involves the homeostasis of Zn2+, K+, and Na+. HGC1, ECE1, UME6, HWP1, HYR1, and HYR1, hypha-specific genes; ALS, agglutinin-like sequence; CaM, calmodulin; CnA, the a subunit of calcineurin; CnB, the b subunit of calcineurin; ATG, autophagy-related genes. The details are shown in the text.
Antifungal activity of compounds against Candida albicans by ion disruption.
| 1,2,3-triazole 3a | FLCR
| – | 37 | 24 | MIC = 25 μg/mL | Pma1 inhibitor | Irfan et al., |
| NC1175 | RPMI 1640 | 35 | 48 | MIC80 = 1.66 μg/mL | Interact with Pma1 | Manavathu et al., | |
| Concanamycin A | YPD | –a | – | MIC = 1.7 μg/mL | Inhibit V-ATPase-c-ring | Okoli et al., | |
| EDTA | SDA | 37 | 24 | MIC = 0.625 mg/mL | Calcium chelators | Ates et al., | |
| EGTA | SDA | 37 | 24 | MIC = 20 mg/mL | Calcium chelators | Ates et al., | |
| Verapamil | RPMI 1640 | 37 | 24 | – | Calcium channel blockers | Yu et al., | |
| Beauvericin | RPMI 1640 | – | – | MIC90 = 8 μg/mL | Elevate intracellular calcium | Tong et al., | |
| Silibinin | YPD | 28 | 48 | MIC = 40 μM | Disrupt calcium homeostasis in cytoplasm and mitochondria | Yun and Lee, | |
| Ciclopirox Olamine | RPMI 1640 | 37 | – | MIC80 = 2.0 μg/mL | Iron chelators | Niewerth et al., | |
| Geraniol | YPD | 30 | 48 | MIC80 = 225–250 μg/mL | Disrupt iron homeostasis | Singh et al., | |
| EMAC | FLCR
| RPMI 1640 | 35 | 72 | MIC = 0.19–3.12 μg/mL | Iron chelators | Meleddu et al., |
| Transferrin | RPMI 1640 | 35 | 20 | MIC = 60 μg/mL | Sequester iron and disrupt membrane potential | Lin et al., | |
| ZAC307 | YPD | 30 | 24 | MIC50 = 0.6 μg/mL | Zinc chelators | O'Hanlon Cohrt et al., | |
| ZAC989 | YPD | 30 | 24 | MIC50 = 0.4 μg/mL | Zinc chelators | O'Hanlon Cohrt et al., | |
| Histatin 5 | YPD | 30 | 24 | MIC = 4–16 μg/mL | Interact with Trk1 and Tok1 | Baev et al., | |
| Cassia spectabilis | RPMI 1640 | 37 | 24 | MIC = 6.25 mg/mL | Potassium leakage | Torey et al., | |
| Chlorogenic acid | YPD | 28 | 15 | MIC = 320 μg/mL | Potassium leakage | Yun and Lee, | |
| Lactoferrin | SDB | 30 | 20 | – | Potassium leakage through Tok1 | Andrés et al., | |
MIC, minimum inhibitory concentration; YPD, yeast–polypeptone–glucose broth; SDA, Sabouraud dextrose agar; SDB, Sabouraud dextrose broth; FLC.